Skip to main content
. Author manuscript; available in PMC: 2009 Jun 15.
Published in final edited form as: Stem Cells. 2009 Jan;27(1):175–182. doi: 10.1634/stemcells.2008-0583

Figure 4.

Figure 4

Percentage of circulating human CD45+ cells up to 24 weeks post transplant using 3 cord blood compositions. CD34+ selected cord blood (CB CD34, 2×106 cells, busulfan 50mg/kg, n=7), unselected cord blood (unsel CB, 1×108 cells, busulfan 25mg/kg, n=6), CD3 selected cord blood (CD3, 2×107 cells, busulfan 25mg/kg, n=3). CB, cord blood.